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Purpose: There are well known negative consequences 
associated with the diagnosis, management and treatment of 
prostate cancer. We sought to determine what the perceived 
unmet information and supportive care needs of Canadian 
prostate cancer patients were according to treatment. 
Methods and Materials: Surveys were conducted in 2014-15 using 
a random sample of men diagnosed with PC in 2012 from three 
provincial cancer registries (BC, AB, SK). Survey questions 
included demographics, treatment received, information and 
support needs. Participants were asked if they had met or unmet 
needs within last two months regarding 42 topics included in six 
domains: physical, psychological, sexual, care and support, 
health information, and prostate cancer-specific. An unmet need 
(UMN) was defined in the survey as a need that was not fully met 
as a result of having prostate cancer or its treatments. 
Results: Provincial response rates ranged from 46%-55%. Patients 
(n = 810) were grouped into the following treatment categories: 
active surveillance (AS) (n = 37), watchful waiting (n = 25), 
surgery (S) (n = 294), S+external beam radiotherapy (EBRT) (n = 
24), S+EBRT+hormone therapy (HT) (n = 22), EBRT (n = 68), 
EBRT+HT (n = 100), brachytherapy (BT) (n = 112), BT+HT (n = 19), 
EBRT+BT (n = 16), EBRT+BT+HT (n = 30), HT (n = 47), 
chemotherapy (CT) (n = 16). The mean total number of UMN 
(maximum 42) ranged from 1.8 to 8.5 across treatment groups. 
Patients who received local therapies had a higher mean total 
number of UMN (mean = 3.8) compared to AS (mean = 2.3) (p = 
0.034). Treatment groups differed in mean UMN in the five 
physical domain questions (p = 0.001). Patients receiving CT 
(mean = 1.6) or EBRT+BT+HT (mean = 0.7) had higher UMN than 
all others (all means < 0.5).  
The groups also differed in their mean UMN in the eight prostate 
cancer specific domain topics (p = 0.04). CT patients had the 
highest UMN (mean = 1.7). Patients undergoing AS (mean = 0.4) 
had fewer UMN compared to radiation treatments (BT+HT, 
EBRT+BT+HT, EBRT+HT) (means = 0.9-1.3). Patients receiving 
BT+HT (mean = 1.3) had higher UMN compared to EBRT or BT 
alone (mean = 0.6 for each).  
Groups also differed in their mean UMN in the nine psychological 
domain topics (p = 0.05). CT patients (mean = 2.5) had higher 
UMN than other groups (means = 0.4-1.6). Surgical patients had 
higher sexual UMN (mean = 0.8) compared to other radiation 
local therapies (means=0.4-0.6) (p < 0.05) and AS (mean = 0.4) 
(p = 0.034). UMN regarding cancer fears, uncertainty, sexual 
feelings and relationships, loss of manhood or hot flushes were 
reported at high frequency (> 20%) in at least four of the 
treatment groups.  
Conclusions: There is a range of UMN for men with PC across 
different domains and differences between treatment groups. 
Identification of high UMN may serve as impetus to further 
address these needs by the healthcare system and community. 
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Purpose: Every person who experiences cancer requires 
continuous support as they transition between the different 
stages of their cancer journey. Currently in Alberta, there are 
over 130,000 cancer survivors in the post-treatment phase of 
follow up, surveillance and monitoring, and/or receiving 
adjuvant treatment. It is expected this number will double in the 
next 10 years. These patients are at increased risk for 
reoccurrence, developing a second unrelated cancer, and other 
late and long-term effects of their diagnosis and treatment. 
CancerControl Alberta has a key leadership role in collaborating 
with all key stakeholders to determine a sustainable way forward 
to meet these needs, now and in the future. 
Methods and Materials: Transitional support is identified as 
essential to providing quality health care (AHS Patient First 
Strategy, 2015) and is defined as the coordination and continuity 
of health care as patients transfer between internal and external 
providers, and across sites/systems over time. Development of a 
“Transition of Care Model” to improve transitions for well 
patients post-treatment is underway through the Provincial 
Integrated Cancer Survivorship Project-PICSP (2014-2016). While 
currently underway, several key elements required to improve 
transitional care have emerged including: general and tailored 
self-management and decision support resources, and optimized 
processes for care coordination between CCA and Primary Care. 
Results: This presentation will outline progress to date and 
lessons learned, concentrating on three aspects of the transitions 
of care model: provincial follow up guidelines, patient education 
and self-management resources, and decision support and care 
coordination improvements for healthcare providers. 
Conclusions: To live well beyond the diagnosis and treatment of 
cancer, patients require an effective transition to ensure 
continuous care, self-empowerment and management of their 
symptoms, and clear steps for re-entry into the cancer system if 
needed. 
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Purpose: To obtain information from prostate cancer patients 
regarding their needs in the domain of sexual health care. The 
information, combined with clinical experience and expert 
knowledge of the health care team would enable the 
optimization of current resources and/or creation of new 
resources to meet the needs of patients and their partners 
related to sexual health. It could also provide baseline data with 
which to evaluate services and resources developed as a result 
of the needs assessment process. 
Methods and Materials: A questionnaire was adapted by the 
investigators from a validated questionnaire utilized by the 
Alberta Health Board, investigating patients’ needs regarding 
sexual health care. Quantitative data was collected via the 
questionnaire; a four point Likert scale was utilized. Qualitative 
data was collected from the comments section after each 
question. Quantitative data was analyzed in terms of percentage 
responses. Qualitative data was subject to thematic analysis and 
reported according to identified themes. All prostate cancer 
patients, at all stages in the cancer continuum, were eligible to 
participate. 
Results: One hundred patients were surveyed over a four month 
period. Forty-four patients responded although not every 
question was answered. Eighteen of 36 (50%) reported receiving 
written information and 22/38 (58%) verbal information about 
sexual health as it related to their cancer and treatment. Topics 
patients reported wanting to receive more information on were: 
1) erections; 2) libido; and 3) fatigue.
Conclusions: Patients had differing experiences regarding the 
provision of sexual health information and services during their 
cancer treatment trajectory. Patients reported a variety of 
issues that were concerning to them on which they would like to 
receive more information. Adopting a framework for service 
delivery e.g. the PLISSIT model, may help in meeting the needs 
of patients while utilizing current resources. It may also 
facilitate service evaluation in the future. 
